A61K 2035/124
The cells being hematopoietic, bone marrow derived or blood cells
Official title: {the cells being hematopoietic, bone marrow derived or blood cells}
A61K2035/124 (The cells being hematopoietic, bone marrow derived or blood cells) appears on 1,382 US grants and 2,395 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,382
- Published applications
- 2,395
- Assignees
- 960
- Inventors
- 3,195
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 6 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 12 | 0 |
| 1997 | 11 | 0 |
| 1998 | 31 | 0 |
| 1999 | 22 | 0 |
| 2000 | 27 | 0 |
| 2001 | 20 | 9 |
| 2002 | 21 | 62 |
| 2003 | 29 | 96 |
| 2004 | 27 | 94 |
| 2005 | 22 | 86 |
| 2006 | 21 | 77 |
| 2007 | 9 | 62 |
| 2008 | 24 | 83 |
| 2009 | 23 | 74 |
| 2010 | 34 | 93 |
| 2011 | 40 | 113 |
| 2012 | 35 | 102 |
| 2013 | 51 | 69 |
| 2014 | 53 | 106 |
| 2015 | 66 | 118 |
| 2016 | 77 | 156 |
| 2017 | 71 | 189 |
| 2018 | 109 | 133 |
| 2019 | 112 | 151 |
| 2020 | 87 | 126 |
| 2021 | 85 | 93 |
| 2022 | 75 | 88 |
| 2023 | 41 | 72 |
| 2024 | 52 | 56 |
| 2025 | 51 | 52 |
| 2026 | 22 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Haematopoietic stem/progenitor cells29 Sep 2026US 12,747,424 B2Murdoch Childrens Research Institute
- Compositions and methods for haematopoietic stem cell transplantation8 Sep 2026US 12,729,371 B2Fondazione Telethon
- Stabilized radiolabeled anti-CD45 immunoglobulin compositions18 Aug 2026US 12,708,678 B2Actinium Pharmaceuticals, Inc.
- HLA class II-restricted DQ T cell receptors against RAS with G13D mutation16 Jun 2026US 12,655,195 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Membrane protein scaffolds for exosome engineering9 Jun 2026US 12,648,907 B2Lonza Sales AG
- Intranasal delivery of cd34+ cells for the treatment of stroke8 Oct 2026US 2026/0306537 A1Cellprothera
- Generation of a mesenchymal stromal cell bank from the pooled mononuclear cells of multiple bone marrow donors8 Oct 2026US 2026/0308528 A1Drk Blutspendedienst Baden-WüRttemberg-Hessen Ggmbh
- Compositions and methods for the treatment of intestinal inflammation1 Oct 2026US 2026/0294973 A1Ann & Robert H. Lurie Children's Hospital of Chicago
- Pluripotent stem cell that can be isolated from body tissue1 Oct 2026US 2026/0297512 A1MuseCell Innovations Pte. Ltd.
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
Most cited
By later US patents
- Human mesenchymal stem cells813US 5,486,359 AOsiris Therapeutics, Inc. · 1996
- Method for treating connective tissue disorders633US 5,226,914 A1993
- Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration549US 6,200,606 B1DePuy Orthopaedics, Inc. · 2001
- Connective tissue regeneration using human mesenchymal stem cell preparations470US 5,811,094 AOsiris Therapeutics, Inc. · 1998
- Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells444US 5,197,985 A1993